Skip to main content

HB 1292 (2026)

Expand Right to Try and regulate stem cell therapies

This bill did not become law.

Last updated 2026-03-15 5:43 pm
Summary:

Expands the "Right to Try" act to include patients with qualifying severe illnesses and establishes regulations for the use of regenerative stem cell therapies.

Bill Sponsor:
Erica Layon
Republican party logo
Status:
HOUSE
Status Detail:
Interim Study
Public Hearing Date:
02/11/2026 01:00 pm
Public Hearing Location:
GP Room 230
House Voting Date:
03/05/2026
Browse related articles and bills:
Thank you to our sponsors and donors